Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin

David J. Curtis

Clinical Haematology, Alfred Health, Melbourne, VIC, Australia

Sushrut S. Patil

Clinical Haematology, Alfred Health, Melbourne, VIC, Australia

John Reynolds

Clinical Haematology, Alfred Health, Melbourne, VIC, Australia

Duncan Purtill

Haematology Service, Fiona Stanley Hospital–PathWest Laboratory Medicine, Perth, WA, Australia

Clinton Lewis

Haematology, Auckland City Hospital, Auckland, New Zealand

David S. Ritchie

Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia

David J. Gottlieb

Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney

David T. Yeung

Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia

Eric Wong

Haematology, Austin Health, Melbourne, VIC, Australia

Siok-Keen Tey

Travis Perera

Haematology, Wellington Blood and Cancer Centre, Wellington, New Zealand

John Moore

Haematology, St. Vincent’s Health Network, Sydney

Rachel M. Koldej

Australian Cancer Research Foundation Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, VIC, Australia

Richard De Abreu Lourenco

Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney

John Stubbs

Australasian Leukaemia and Lymphoma Group, Melbourne, VIC, Australia

C. Orla Morrissey

Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, VIC, Australia

Nadia Munsef

Australasian Leukaemia and Lymphoma Group, Melbourne, VIC, Australia

Andrea Arenas

Australasian Leukaemia and Lymphoma Group, Melbourne, VIC, Australia

Geoffrey R. Hill